1Qin DX, Hu YH, YanJH, et al. Analysis of 1379 patients with nasopharyngeal carcinoma treated by radiation [J]. Cancer, 1988,61(6): 1117-1123
2Perez CA, Devineni VR, Marcial-Vega V, et al. Carcinoma of the nasopharynx: factors affecting prognosis[J]. IntJ Radiat Oncol Biol Phys, 1992, 23(2): 271-280
3Bailet JW, Mark RJ, Abemayor E, et al. Nasopharyngeal carcinoma: treatment results with primary radiation therapy[J]. Laryngoscope, 1992, 102(9): 965-972
4Santos JA, Gonzalez C, Cuesta P, et al. Impact of changes in the treatment of nasopharyngeal carcinoma: an experience of 30 years [J]. Radiotherapy and Oncology, 1995, 36(2): 121-127
5Yan J H, Qin D X, Hu YH, et al. Management of local residual primary lesion of nasopharyngeal carcinoma (NPC): are higher doses benificial[J]? IntJ Radiat Oncol Biol Phys, 1989, 16(6):1465-1469
6YanJH, Xu GZ, Hu YH, et al. Management of local residual primary lesion of nasopharyngeal carcinoma: Ⅱ . result of prospective randomized trial on booster dose[J]. Int J Radiat Oncol Biol Phys, 1990, 18(2): 295～298
7Teo PML, Leung SF, Lee WY, et al. Intracavitary brachytherapy significantly enhances local control of early T-stage nasopharyngeal carcinoma: the existence of a dose-tumor-control relationship above conventional tumoricidal dose [J]. Int J Radiat Oncol Bi
